Literature DB >> 16882330

Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication.

Masayuki Mashimo1, Manabu Nishikawa, Kazuhide Higuchi, Masaki Hirose, Qian Wei, Anwarul Haque, Eiji Sasaki, Masatsugu Shiba, Kazunari Tominaga, Toshio Watanabe, Yasuhiro Fujiwara, Tetsuo Arakawa, Masayasu Inoue.   

Abstract

BACKGROUND: Helicobacter pylori infection has been reported to cause gastroduodenal ulcer, mucosa-associated lymphoid tissue lymphoma, and gastric cancer. Recent studies have suggested that H. pylori infection may also associate with other diseases, including hematologic and dermatologic disorders, and cardiovascular injury, by unknown mechanisms.
METHODS: Production of reactive oxygen species (ROS) was determined in peripheral blood samples from 86 patients (34 H. pylori-negative and 52 H. pylori-positive subjects) using a highly sensitive chemiluminescence probe, L-012 (8-amino-5-chloro-7-phenylpyrido(3,4-d) pyridazine-1 and 4 (2H, 3H) dione). Eleven H. pylori-positive individuals were also analyzed their ROS production in peripheral blood after H. pylori eradication.
RESULTS: ROS production was significantly higher in individuals with H. pylori infection than in those without infection. Enhanced production of ROS was decreased significantly after eradication of H. pylori. No correlation was found between the extent of ROS production and sex, age, smoking status, alcohol ingestion, use of medications, or serum level of C-reactive protein.
CONCLUSION: These findings suggest that ROS production was enhanced in peripheral blood by H. pylori infection. Chemiluminescence analysis of blood samples using L-012 permits evaluation of systemic oxidative stress in patients with H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882330     DOI: 10.1111/j.1523-5378.2006.00410.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  8 in total

1.  Reactive oxygen species and gastric cancer risk: a large nested case-control study in Japan.

Authors:  Enbo Ma; Shizuka Sasazuki; Taichi Shimazu; Norie Sawada; Taiki Yamaji; Motoki Iwasaki; Manami Inoue; Shoichiro Tsugane
Journal:  Eur J Epidemiol       Date:  2015-04-03       Impact factor: 8.082

Review 2.  Extraintestinal manifestations of Helicobacter pylori: a concise review.

Authors:  Frank Wong; Erin Rayner-Hartley; Michael F Byrne
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 3.  Lipid raft redox signaling: molecular mechanisms in health and disease.

Authors:  Si Jin; Fan Zhou; Foad Katirai; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

4.  Oxidative stress markers correlate with renal dysfunction and thrombocytopenia in severe leptospirosis.

Authors:  Alan M Araújo; Eliana A G Reis; Daniel A Athanazio; Guilherme S Ribeiro; José E Hagan; Guilherme C Araujo; Alcineia O Damião; Nicolli S Couto; Albert I Ko; Alberto Noronha-Dutra; Mitermayer G Reis
Journal:  Am J Trop Med Hyg       Date:  2014-02-03       Impact factor: 2.345

Review 5.  The molecular pathology of rosacea.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  J Dermatol Sci       Date:  2009-05-29       Impact factor: 4.563

Review 6.  Cross talk between ceramide and redox signaling: implications for endothelial dysfunction and renal disease.

Authors:  Pin-Lan Li; Yang Zhang
Journal:  Handb Exp Pharmacol       Date:  2013

7.  Effect of H. pylori Infection on Cytokine Profiles and Oxidative Balance in Subjects with Chronic Alcohol Ingestion.

Authors:  Baoge Qu; Jiliang Su; Zhongdong Wang; Yafei Wang; Xinghai Han; Hui Wang; Yuanxun Liu; Yiguo Jia; Jindun Pan; Guangying Ren
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 8.  Bone Fragility in Gastrointestinal Disorders.

Authors:  Daniela Merlotti; Christian Mingiano; Roberto Valenti; Guido Cavati; Marco Calabrese; Filippo Pirrotta; Simone Bianciardi; Alberto Palazzuoli; Luigi Gennari
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.